Ramucirumab Intravenous and Tacrolimus Extended-Release Capsules
Determining the interaction of Ramucirumab Intravenous and Tacrolimus Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ramucirumab Intravenous-Tacrolimus Extended-Release Tablets
- Ramucirumab Intravenous-Tacrolimus Granules for Suspension
- Ramucirumab Intravenous-Tacrolimus Injection
- Ramucirumab Intravenous-Tacrolimus Intravenous
- Ramucirumab Intravenous-Tacrolimus oral and injection
- Ramucirumab Intravenous-Tacrolimus Oral, Intravenous
- Tacrolimus Extended-Release Capsules-Ranexa
- Tacrolimus Extended-Release Capsules-Ranibizumab
- Tacrolimus Extended-Release Capsules-Ranibizumab Intraocular
- Tacrolimus Extended-Release Capsules-Ranibizumab ophthalmic
- Tacrolimus Extended-Release Capsules-Ranitidine
- Tacrolimus Extended-Release Capsules-Ranitidine Capsule